Current Research Information SysTem In Norway
 
 

 English version


 
Hovedside
Forskningsresultater/NVI
Forskere
Prosjekter
Forskningsenheter
Logg inn
Om Cristin
 
 
   
Eksporter til


Viser treff 1-50 av 261 << Forrige 1 2 3 4 5 6    Neste >>

2018
1 Birkeland, Einar Elvbakken; Zhang, Shan; Poduval, Deepak; Geisler, Jürgen; Nakken, Sigve; Vodak, Daniel; Meza, Leonardo Zepeda; Hovig, Eivind; Myklebost, Ola; Knappskog, Stian; Lønning, Per Eystein.
Patterns of genomic evolution in advanced melanoma. Nature Communications 2018 ;Volum 9:2665. s. 1-12
AHUS HAUKELAND OUS UiB UiO Untitled
 
2 Gouravan, Sarina; Meza, Leonardo Zepeda; Myklebost, Ola; Stratford, Eva Wessel; Munthe, Else.
Preclinical evaluation of vemurafenib as therapy for BRAFV600E mutated sarcomas. International Journal of Molecular Sciences 2018 ;Volum 19:969.(4) s. 1-15
OUS UiB Untitled
 
3 Hanes, Robert.
Precision medicine for the treatment of a highly malignant and resistant type of liposarcoma. Universitetet i Oslo 2018 Series of dissertations submitted to the Faculty of Mathematics and Natural Sciences, University of Oslo.(1941)
UiB OUS Untitled
 
4 Kresse, Stine Henrichson; Namløs, Heidi Maria; Lorenz, Susanne; Berner, Jeanne-Marie; Myklebost, Ola; Bjerkehagen, Bodil; Meza, Leonardo Zepeda.
Evaluation of commercial DNA and RNA extraction methods for high-throughput sequencing of FFPE samples. PLoS ONE 2018 ;Volum 13:e0197456.(5) s. 1-12
OUS UiB Untitled
 
5 Ljøsne, Isabelle Budin.
Bringing personalized medicine to people. Universitetet i Oslo 2018 (ISBN 978-82-8377-210-4)
FHI UiB UiO Untitled
 
6 Løvf, Marthe; Zhao, Sen; Axcrona, Ulrika; Johannessen, Bjarne; Bakken, Anne Cathrine; Carm, Kristina Totland; Hoff, Andreas Midbøe; Myklebost, Ola; Meza, Leonardo Zepeda; Lie, Kathrine; Axcrona, Karol; Lothe, Ragnhild A; Skotheim, Rolf I..
Multifocal primary prostate cancer exhibits high degree of genomic heterogeneity. European Urology 2018 s. 1-8
AHUS OUS UiB Untitled
 
7 Misund, Kristine; Hofste op Bruinink, Davine; Coward, Eivind; Hoogenboezem, Remco; Rustad, Even Holth; Hovig, Eivind; Sundan, Anders; Myklebost, Ola; Sonneveld, Pieter; Waage, Anders.
Clonal Evolution of Multiple Myeloma After Treatment with Novel Agents. 2nd. International NTNU Symposium on Current and Future Clinical Biomarkers of Cancer; 2018-06-14 - 2018-06-15
NTNU STO UiB Untitled
 
8 Misund, Kristine; Hofste op Bruinink, Davine; Coward, Eivind; Hoogenboezem, Remco; Rustad, Even Holth; Hovig, Eivind; Sundan, Anders; Myklebost, Ola; Sonneveld, Pieter; Waage, Anders.
Whole-Exome and mRNA Sequencing of Multiple Myeloma Reveal Transformation to a More High-Risk and Proliferative Tumor at Relapse. American Society of Hematology (ASH) 2018; 2018-12-01 - 2018-12-04
NTNU STO UiB Untitled
 
9 Misund, Kristine; Hofste op Bruinink, Davine; Coward, Eivind; Hoogenboezem, Remco; Rustad, Even Holth; Hovig, Eivind; Sundan, Anders; Myklebost, Ola; Sonneveld, Pieter; Waage, Anders.
Whole-Exome and mRNA Sequencing of Multiple Myeloma Reveal Transformation to a More High-Risk and Proliferative Tumor at Relapse. Blood 2018
NTNU STO UiB Untitled
 
10 Nakken, Sigve; Fournous, Ghislain; Vodak, Daniel; Aasheim, Lars Birger; Myklebost, Ola; Hovig, Eivind.
Personal Cancer Genome Reporter: Variant interpretation report for precision oncology. Bioinformatics 2018 ;Volum 34.(10) s. 1778-1780
OUS UiB UiO Untitled
 
11 Namløs, Heidi Maria; Pedersen, Kjetil Boye; Mishkin, Skyler J.; Barøy, Tale; Lorenz, Susanne; Bjerkehagen, Bodil; Stratford, Eva Wessel; Munthe, Else; Kudlow, Brian A.; Myklebost, Ola; Meza, Leonardo Zepeda.
Noninvasive Detection of ctDNA Reveals Intratumor Heterogeneity and Is Associated with Tumor Burden in Gastrointestinal Stromal Tumor. Molecular Cancer Therapeutics 2018 ;Volum 17.(11) s. 2473-2480
OUS UiB Untitled
 
12 Serguienko, Anastassia; Wang, Mengyu; Myklebost, Ola.
Real-time vital mineralization detection and quantification during in vitro osteoblast differentiation. Biological Procedures Online 2018 ;Volum 20:14. s. 1-5
OUS UiB Untitled
 
13 Vodak, Daniel; Lorenz, Susanne; Nakken, Sigve; Aasheim, Lars Birger; Holte, Harald; Bai, Baoyan; Myklebost, Ola; Meza, Leonardo Zepeda; Hovig, Eivind.
Sample-Index Misassignment Impacts Tumour Exome Sequencing. Scientific Reports 2018 ;Volum 8:5307. s. 1-6
OUS UiB UiO Untitled
 
2017
14 Aamdal, Steinar; Bentzen, Heidi Beate; Borge, Ole Johan; Erikstein, Bjørn K; Grimsgaard, Sameline; Hovig, Johannes Eivind; Myklebost, Ola; Widerberg, Ketil.
Åpne Nordens grenser for forskning og behandling. Aftenposten (morgenutg. : trykt utg.) 2017
OUS UiB UiO UiT Untitled
 
15 Behjati, Sam; Tarpey, Patrick S.; Haase, Kerstin; Ye, Hongtao; Young, Matthew D.; Alexandrov, Ludmil B.; Farndon, Sarah J.; Collord, Grace; Wedge, David C.; Martincorena, Inigo; Cooke, Susanna L.; Davies, Helen; Mifsud, William; Lidgren, Mathias; Martin, Sancha; Latimer, Calli; Maddison, Mark; Butler, Adam P.; Teague, Jon W.; Pillay, Nischalan; Shlien, Adam; McDermott, Ultan; Futreal, P. Andrew; Baumhoer, Daniel; Zaikova, Olga; Bjerkehagen, Bodil; Myklebost, Ola; Amary, M. Fernanda; Tirabosco, Roberto; Van Loo, Peter; Stratton, Michael R.; Flanagan, Adrienne M.; Campbell, Peter J..
Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma. Nature Communications 2017 ;Volum 8:15936. s. 1-8
OUS UiB Untitled
 
16 Berg, Kaja Christine Graue; Eide, Peter Andreas Wold; Eilertsen, Ina Andrassy; Johannessen, Bjarne; Bruun, Jarle; Danielsen, Stine Aske; Bjørnslett, Merete Pauline; Meza, Leonardo Zepeda; Eknæs, Mette; Lind, Guro Elisabeth; Myklebost, Ola; Skotheim, Rolf I.; Sveen, Anita; Lothe, Ragnhild A.
Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies. Molecular Cancer 2017 ;Volum 16:116. s. 1-16
OUS UiB UiO Untitled
 
17 Coward, Eivind; Misund, Kristine; Hofste op Bruinink, Davine; Hoogenboezem, Remco; Rustad, Even Holth; Myklebost, Ola; Sundan, Anders; Sonneveld, Pieter; Waage, Anders.
Exome sequencing of multiple myeloma at sequential time points. Trondheim - Oslo Genome Dynamics Workshop; 2017-06-15 - 2017-06-16
NTNU UiB Untitled
 
18 Engkvist, Marie Elise; Stratford, Eva Wessel; Lorenz, Susanne; Meza, Leonardo Zepeda; Myklebost, Ola; Munthe, Else.
Analysis of the miR-34 family functions in breast cancer reveals annotation error of miR-34b. Scientific Reports 2017 ;Volum 7:9655. s. 1-10
OUS UiB Untitled
 
19 Helland, Åslaug; Brustugun, Odd Terje; Nakken, Sigve; Halvorsen, Ann Rita; Dønnem, Tom; Bremnes, Roy M.; Busund, Lill-Tove; Sun, Jinchang; Lorenz, Susanne; Solberg, Steinar; Jørgensen, Lars Hilmar; Vodak, Daniel; Myklebost, Ola; Hovig, Eivind; Meza, Leonardo Zepeda.
High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival. International Journal of Cancer 2017 ;Volum 141.(1) s. 184-190
OUS UiO UiT UNN Untitled
 
20 Misund, Kristine; Hofste op Bruinink, Davine; Coward, Eivind; Hoogenboezem, Remco; Rustad, Even Holth; Hovig, Eivind; Sundan, Anders; Myklebost, Ola; Sonneveld, Pieter; Waage, Anders.
Detection of mutations in Multiple Myeloma during different stages of disease. NMSG plenary meeting; 2017-09-07 - 2017-09-08
NTNU UiB UiO Untitled
 
21 Myklebost, Ola.
Sarcomas: Genomic Landscape and potential targets.. Annual meeting 2017 NSGO; 2017-05-04 - 2017-05-05
UiB Untitled
 
22 Namløs, Heidi Maria; Zaikova, Olga; Bjerkehagen, Bodil; Vodak, Daniel; Hovig, Johannes Eivind; Myklebost, Ola; Pedersen, Kjetil Boye; Meza, Leonardo Zepeda.
Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report. BMC Cancer 2017 ;Volum 17:29. s. 1-6
OUS Untitled
 
23 Rustad, Even Holth; Coward, Eivind; Skytøen, Emilie R; Misund, Kristine; Holien, Toril; Standal, Therese; Børset, Magne; Beisvag, Vidar; Myklebost, Ola; Meza, Leonardo Zepeda; Hong, Yan Dai; Sundan, Anders; Waage, Anders.
Monitoring multiple myeloma by quantification of recurrent mutations in serum. Haematologica 2017 ;Volum 102.(7) s. 1266-1272
NTNU OUS STO UiB Untitled
 
24 Serguienko, Anastassia; Hanes, Robert; Grad, Iwona; Wang, Mengyu; Myklebost, Ola; Munthe, Else.
PP2A regulatory subunit b55γ is a gatekeeper of osteoblast maturation and lineage maintenance. Stem Cells and Development 2017 ;Volum 26.(19) s. 1375-1383
OUS UiB Untitled
 
25 Sveen, Anita; Johannessen, Bjarne; Tengs, Torstein; Danielsen, Stine Aske; Eilertsen, Ina Andrassy; Lind, Guro Elisabeth; Berg, Kaja Christine Graue; Leithe, Edward; Meza, Leonardo Zepeda; Domingo, Enric; Myklebost, Ola; Kerr, David; Tomlinson, Ian; Nesbakken, Arild; Skotheim, Rolf I.; Lothe, Ragnhild A.
Multilevel genomics of colorectal cancers with microsatellite instability – clinical impact of JAK1 mutations and consensus molecular subtype 1. Genome Medicine 2017 ;Volum 9.(1)
OUS UiO Untitled
 
2016
26 Ballinger, Mandy L.; Goode, David L.; Ray-Coquard, Isabelle; James, Paul A.; Mitchell, Gillian; Niedermayr, Eveline; Puri, Ajay; Schiffman, Joshua D.; Dite, Gillian S.; Cipponi, Arcadi; Maki, Robert G.; Brohl, Andrew S.; Myklebost, Ola; Stratford, Eva Wessel; Lorenz, Susanne; Ahn, Sung-Min; Ahn, Jin-Hee; Kim, Jeong Eun; Shanley, Sue; Beshay, Victoria; Randall, Robert Lor; Judson, Ian; Seddon, Beatrice; Campbell, Ian G.; Young, Mary-Anne; Sarin, Rajiv; Blay, Jean-Yves; O'Donoghue, Seán I.; Thomas, David M..
Monogenic and polygenic determinants of sarcoma risk: an international genetic study. The Lancet Oncology 2016 ;Volum 17.(9) s. 1261-1271
OUS Untitled
 
27 Barøy, Tale; Chilamakuri, Chandra Sekhar Reddy; Lorenz, Susanne; Sun, Jinchang; Bruland, Øyvind; Myklebost, Ola; Meza-Zepeda, Leonardo.
Genome analysis of osteosarcoma progression samples identifies FGFR1 overexpression as a potential treatment target and CHM as a candidate tumor suppressor gene. PLoS ONE 2016
OUS UiO Untitled
 
28 Halvorsen, Ann Rita; Silwal-Pandit, Laxmi; Meza, Leonardo Zepeda; Vodak, Daniel; Vu, Phuong Ngoc Thi; Sagerup, Camilla Maria Troøien; Hovig, Johannes Eivind; Myklebost, Ola; Børresen-Dale, Anne-Lise; Brustugun, Odd Terje; Helland, Åslaug.
TP53 mutation spectrum in smokers and never smoking lung cancer patients. Frontiers in Genetics 2016 ;Volum 7.(MAY)
OUS UiO Untitled
 
29 Hanes, Robert; Grad, Iwona; Lorenz, Susanne; Stratford, Eva Wessel; Munthe, Else; Chilamakuri, Chandra Sekhar Reddy; Meza, Leonardo Zepeda; Myklebost, Ola.
Preclinical evaluation of potential therapeutic targets in dedifferentiated liposarcoma. OncoTarget 2016 ;Volum 7.(34) s. 54583-54595
OUS Untitled
 
30 Kager, Leo; Whelan, Jeremy; Dirksen, U; Hassan, Bass; Anninga, Jacob; Bennister, L; Bovée, Judith; Brennan, B. A.; Broto, JM; Brugieres, L; Cleton-Jansen, Anne-Marie; Copland, C; Dutour, A; Fagioli, F; Ferrari, S; Fiocco, M; Fleuren, E; Gaspar, N; Gelderblom, Hans; Gerrand, C; Gerss, J; Gonzato, O; van der Graaf, W; Hecker-Nolting, S; Herrero-Martin, D; Klco-Brosius, S; Kovar, H; Ladenstein, R; Lancia, C; LeDeley, MC; McCabe, MG; Metzler, M; Myklebost, Ola; Nathrath, Michaela; Picci, Piero; Potratz, J; Redini, F; Richter, GH; Reinke, D; Rutkowski, P; Scotlandi, Katia; Strauss, S; Thomas, David M; Tirado, OM; Tirode, F; Vassal, GH; Bielack, Stefan S..
The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report. Clinical sarcoma research 2016
UiB Untitled
 
31 Lorenz, Susanne; Barøy, Tale; Sun, Jinchang; Nome, Torfinn; Vodak, Daniel; Bryne, Jan Christian; Håkelien, Anne-Mari; Fernandez-Cuesta, Lynnette; Möhlendick, B; Rieder, H; Szuhai, K; Zaikova, Olga; Ahlquist, Terje Cruickshank; Thomassen, Gard O Sundby; Skotheim, Rolf Inge; Lothe, Ragnhild A; Tarpey, P; Campbell, P.; Flanagan, A; Myklebost, Ola; Meza, Leonardo Zepeda.
Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations. OncoTarget 2016 ;Volum 7.(5) s. 5273-5288
OUS UiO Untitled
 
32 Myklebost, Ola.
NoSarC-prosjektetr har deltatt I en studie av arvelige faktorer som kan bidra til at man får sarkom. Sarkomen-Et nyhetsbrev fra pasientforeningen [Tidsskrift] 2016-02-01
UiB Untitled
 
33 Myklebost, Ola.
Statsbudsjettet 2017: “ - Kan rekke til oppstart av persontilpasset medisin”. Dagens Medisin [Fagblad] 2016-10-10
UiB Untitled
 
34 Myklebost, Ola; Lønning, Per Eystein; Opdalshei, Ole Alexander; Larsen, Monica.
På vei mot en klassedelt kreftomsorg?. Åpent møte arrang. av NCGC og Kreftsatsing i Litteraturhuset [Internett] 2016-04-29
UiB Untitled
 
35 Myklebost, Ola; Lønning, Per Eystein; Ryel, Anne Lise; Thoresen, Sigrid B..
Effektiv behandling for alle.. Bergens Tidende [Avis] 2016-01-12
UiB Untitled
 
36 Myklebost, Ola; Lønning, Per Eystein; Ryel, Anne Lise; Thoresen, Sigrid B..
Persontilpasset kreftmedisin – et spørsmål om prioritering. Åpent møte ved Litteraturhuset i Bergen [Avis] 2016-01-21
UiB Untitled
 
37 Myklebost, Ola; Lønning, Per Eystein; Ryel, Anne Lise; Thoresen, Sigrid B..
På vei mot en klassedelt kreftomsorg?. Aftenposten [Avis] 2016-04-21
UiB Untitled
 
38 Sandhu, Vandana; Wedge, David C.; Lothe, Inger Marie Bowitz; Labori, Knut Jørgen; Dentro, Stefan C.; Buanes, Trond; Skrede, Martina; Larsen, Astrid Marie; Munthe, Else; Myklebost, Ola; Lingjærde, Ole Christian; Børresen-Dale, Anne-Lise; Andersen, Tone Ikdahl; Van Loo, Peter; Nord, Silje; Kure, Elin H..
The genomic landscape of pancreatic and periampullary adenocarcinoma. Cancer Research 2016 ;Volum 76.(17) s. 5092-5102
AHUS USN OUS UiO Untitled
 
39 Stratford, Eva Wessel; Myklebost, Ola.
Vil behandle sjeldne kreftformer med personlig medisinering. Forskning.no [Internett] 2016-01-13
OUS UiB Untitled
 
2015
40 Ju, Y.S; Tubio, J.M.C; Mifsud, W; Davies, H.R; Fu, B; Ramakrishna, M; Li, Y; Yates, L; Gundem, G; Tarpey, P.S; Behjati, S; Papaemmanuil, E; Martin, S; Fullam, A; Gerstung, M; Stratton, M.R; Campbell, P.M; Nik-Zainal, S; Yang, F; McDermott, U; Thompson, A.M; Richardson, A.L; Purdie, C.A; Thomas, G; Desmedt, C; Lakhani, S.R; Eeles, R; Cooper, C; Neal, D.E; Foster, C; Flanagan, A.M; Myklebost, Ola; Eyfjörd, J.E; Børresen-Dale, A.L.; Vincent-Salomon, A; Knappskog, S; Martens, J.W.M; Span, P.N; Aparicio, S; van’t Veer, L.J; Tan, B.K.T; Borg, Å; Tutt, A; Ta, M; Lee, M; Caldas, C; Green, A.R; Nangalia, J; ICGC, Breast Cancer Working Gro; ICGC, Bone Cancer Working Group; ICGC, Prostate Cancer Working Group.
Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells. Genome Research 2015
UiB Untitled
 
41 Kanojia, Deepika; Nagata, Yasunobu; Garg, Manoj; Lee, Dhong Hyun; Sato, Aiko; Yoshida, Kenichi; Sato, Yusuke; Sanada, Masashi; Mayakonda, Anand; Bartenhagen, Christoph; Klein, Hans-Ulrich; Doan, Ngan B.; Said, Jonathan W.; Mohith, Surana; Gunasekar, Swetha; Shiraishi, Yuichi; Chiba, Kenichi; Tanaka, Hiroko; Miyano, Satoru; Myklebost, Ola; Yang, Henry; Dugas, Martin; Meza, Leonardo Zepeda; Silberman, Allan W.; Forscher, Charles; Tyner, Jeffrey W.; Ogawa, Seishi; Koeffler, H. Phillip.
Genomic landscape of liposarcoma. OncoTarget 2015 ;Volum 6.(40) s. 42429-42444
OUS UiO Untitled
 
42 Ljøsne, Isabelle Budin; Bentzen, Heidi Beate; Solbakk, Jan Helge; Myklebost, Ola.
Genomsekvensering i forskning krever ny tilnærming til samtykke. Tidsskrift for Den norske legeforening 2015 ;Volum 135.(22) s. 2031-2032
OUS UiO Untitled
 
43 Myklebost, Ola.
”Cancer Who-done-it”. Article Biennalen 2015; 2015-02-06 - 2015-03-01
OUS UiO Untitled
 
44 Myklebost, Ola.
Gener og kreft. I: Mendels arv - Genetikkens æra. Gyldendal Norsk Forlag A/S 2015 ISBN 978-82-05-45818-5. s. 247-263
OUS UiO Untitled
 
45 Myklebost, Ola.
“Helseforetakene driver beskyttede industribedrifter” Om svak satsing på fagutvikling og utprøvende behandling.. Dagens Medisin [Fagblad] 2015-08-13
OUS UiO Untitled
 
46 Myklebost, Ola.
”It’s All About the Genome”. Handelsblatt Global Edition [Tidsskrift] 2015-04-29
OUS UiO Untitled
 
47 Myklebost, Ola.
”Jakten på en kreftkur”. Aftenposten: A-Magasinet [Avis] 2015-03-19
OUS UiO Untitled
 
48 Myklebost, Ola.
Norwegian Cancer Genomics Consortium: A platform for research on personalized cancer medicine in a public health system. Drug Discovery Today 2015 ;Volum 20.(12) s. 1419-1421
OUS Untitled
 
49 Myklebost, Ola.
Ny studie: Flaks eller uflaks bestemmer oftest om du får kreft – ikke usunn livsstil.Tilfeldige mutasjoner i DNA står bak to av tre krefttilfeller.. TV2 Nyheter [Internett] 2015-01-02
OUS UiO Untitled
 
50 Myklebost, Ola.
Personalized cancer therapy for soft tissue sarcomas: progress and pitfalls. Personalized Medicine 2015 ;Volum 12. s. 593-602
OUS UiO Untitled
 
    Vis neste liste